Betoko Aisha, Matheson Matthew B, Ostovaneh Mohammad R, Miller Julie M, Brinker Jeffrey, Cox Christopher, Lima João A C, Arbab-Zadeh Armin
Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD.
Johns Hopkins University School of Medicine, Baltimore, MD.
Mayo Clin Proc Innov Qual Outcomes. 2021 Feb 26;5(1):46-54. doi: 10.1016/j.mayocpiqo.2020.08.012. eCollection 2021 Feb.
To assess the incidence of contrast-associated acute kidney injury (CAAKI) after repeated exposure to contrast material for computed tomography (CT) and conventional coronary angiography within short intervals.
We studied 651 patients enrolled in the CorE-64 (November 5, 2005-January 30, 2007) and CORE320 (October 21, 2009-August 17, 2011) multicenter studies. Participants with suspected obstructive coronary heart disease were referred for diagnostic cardiac catheterization and underwent coronary CT angiography for research before invasive angiography. Nonionic, low-osmolality iodinated contrast material was used for all imaging.
The median age of the patients was 62 years, and 190 (29%) were women. Major risk factors for acute kidney injury were present in 277 of 651 (43%) patients. The median interval between CT imaging and invasive angiography was 3.1 days (interquartile range, 0.9-8.0 days). The median volume of contrast material was 100 mL for each test. In 16 (2.5%) of 651 patients, CAAKI developed. Of these cases, 1 occurred after the CT scan, whereas 6 were documented after invasive angiography (compared with post-CT creatinine concentration assessment). In 9 patients, CAAKI was found in comparing creatinine concentration after completion of both tests with baseline values (but not compared with post-CT imaging).
Acute kidney injury after repeated exposure to iodinated contrast media within a few days is uncommon even in a population of patients with highly prevalent risk factors. Withholding of clinically indicated contrast-enhanced imaging may therefore not be justified in this setting.
评估在短时间间隔内重复接受计算机断层扫描(CT)和传统冠状动脉造影的造影剂后,造影剂相关急性肾损伤(CAAKI)的发生率。
我们研究了参与CorE-64(2005年11月5日至2007年1月30日)和CORE320(2009年10月21日至2011年8月17日)多中心研究的651例患者。疑似阻塞性冠心病患者被转诊进行诊断性心导管检查,并在有创血管造影前接受冠状动脉CT血管造影以进行研究。所有成像均使用非离子型、低渗性碘化造影剂。
患者的中位年龄为62岁,190例(29%)为女性。651例患者中有277例(43%)存在急性肾损伤的主要危险因素。CT成像与有创血管造影之间的中位间隔时间为3.1天(四分位间距,0.9 - 8.0天)。每次检查造影剂的中位用量为100 mL。651例患者中有16例(2.5%)发生了CAAKI。其中,1例在CT扫描后发生,而6例在有创血管造影后记录(与CT扫描后肌酐浓度评估相比)。在9例患者中,在将两次检查完成后的肌酐浓度与基线值比较时发现了CAAKI(但未与CT扫描后成像比较)。
即使在具有高度普遍危险因素的患者群体中,在几天内重复接触碘化造影剂后发生急性肾损伤也不常见。因此,在这种情况下,不给予临床指示的增强造影成像可能不合理。